Publications by authors named "Islam Sadek"

Claim this Profile
T
Treatment Patterns and Outcomes of Patients With Myelodysplastic Syndrome (MDS) by IPSS-R Scores at Academic Cancer Centers.
Connor Willis, Andre Hejazi, Vonetta L Williams, Craig Comperatore, Srinivas Tantravahi, Islam Sadek

Adv Hematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with asciminib after a prior tyrosine kinase inhibitor in patients with chronic-phase chronic myeloid leukemia.
Ehab L Atallah, Islam Sadek, David Wei, Dominick Latremouille-Viau, Carmine Rossi

Leuk Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HSR25-182: Patient-Physician Communication About Adverse Events and Impact on Quality of Life to Foster Shared Decision-Making in Chronic Myeloid Leukemia.
Kathryn E Flynn, Joan Clements, Karen DeMairo, Jennifer Hiller, David Wei, Islam Sadek

J Natl Compr Canc Netw· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HSR25-174: Impact of Adverse Events on Quality of Life in Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors - Results From the Survey on Humanistic Burden of Intolerance to First or Second TKIs (SHIFT) Study.
Kathryn E Flynn, Joan Clements, Karen DeMairo, Jennifer Hiller, David Wei, Islam Sadek

J Natl Compr Canc Netw· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular response in newly diagnosed chronic-phase chronic myeloid leukemia: prediction modeling and pathway analysis.
Jerald P Radich, Matthew Wall, Susan Branford, Catarina D Campbell, Shalini Chaturvedi, Islam Sadek

Haematologica· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient and Caregiver Insights into the Disease Burden of Myelodysplastic Syndrome.
John Soper, Islam Sadek, Alyson Urniasz-Lippel, Deborah Norton, Marina Ness

Patient Relat Outcome Meas· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study.
Francisco Cervantes, David M Ross, Atanas Radinoff, Francesca Palandri, Alexandr Myasnikov, Islam Sadek

Leukemia· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study.
Francisco Cervantes, David M Ross, Atanas Radinoff, Francesca Palandri, Alexandr Myasnikov, Islam Sadek

Leukemia· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare resource utilization and costs in patients with myelodysplastic syndromes treated with hypomethylating agents: a SEER-Medicare analysis.
Eytan M Stein, Gaetano Bonifacio, Dominick Latrémouille-Viau, Sherry Shi, Annie Guérin, Islam Sadek

J Med Econ· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tyrosine kinase inhibitor therapy discontinuation in patients with chronic myeloid leukemia in chronic phase in the United States after clinical practice guideline updates.
Ehab L Atallah, Islam Sadek, Rodrigo Maegawa, Xiting Cao, Dominick Latremouille-Viau

Leuk Lymphoma· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns and outcomes in patients with myelodysplastic syndromes treated with hypomethylating agents: a SEER-Medicare analysis.
Eytan M Stein, Gaetano Bonifacio, Dominick Latremouille-Viau, Sherry Shi, Annie Guerin, Islam Sadek

Leuk Lymphoma· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MERGE: A Multinational, Multicenter Observational Registry for Myeloproliferative Neoplasms in Asia, including Middle East, Turkey, and Algeria.
Mohamed A Yassin, Ali Taher, Vikram Mathews, Hsin-An Hou, Tahir Shamsi, Islam Sadek

Cancer Med· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis